Study guide
12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units
Key Takeaways Explain This Topic AI
In Oregon, refrigerated drugs are stored at 2–8 °C (35–46 °F) and frozen drugs at −25 to −10 °C (−13 to 14 °F), in pharmaceutical-only units with calibrated, centrally placed thermometers.
Oregon cold-storage temperatures must be monitored continuously and documented either manually twice daily (minimum, maximum and current) or with an automated system, and logs are kept three years.
Oregon treats any out-of-range reading as an excursion: the product is quarantined, the actions and information source are documented, and the deciding pharmacist is recorded.
Oregon vaccine units need buffered probes calibrated to ±0.5 °C, a separate door and thermostat per compartment, twice-daily logging, weekly downloads and quarterly validation.
Oregon's storage rule also covers conditions during delivery to patients and allows storage in a registered Drug Room that meets pharmacy standards.
Last updated: October 2026
Why this matters
Area 4.2 covers the "possession, storage, and handling of non-hazardous drugs." Oregon's storage rule, OAR 855-041-1036 , is detailed, especially for refrigerated and vaccine storage, and the Board checks it on every inspection. Exam items ask about temperature ranges, monitoring frequency, excursion documentation and vaccine-unit validation.
General storage duties (OAR 855-041-1036(1))
A pharmacy must store all drugs :
According to the manufacturer's published guidelines or USP .
In appropriate conditions of temperature, light, humidity, sanitation, ventilation and space .
In appropriate conditions during transfers between facilities and to patients , which covers deliveries and mail.
Drugs that are outdated, adulterated, misbranded or suspect must be quarantined. A retail drug outlet may store drugs in another location registered as a Drug Room if that location meets all pharmacy storage and security requirements (OAR 855-041-1036(4)).
Cold storage and monitoring (OAR 855-041-1036(2))
- Requirement Standard
- Refrigerated products 2 to 8 °C (35 to 46 °F)
- Frozen products −25 to −10 °C (−13 to 14 °F)
- Thermometer Centrally placed , accurate and calibrated
- Dedicated use Pharmaceuticals only . No food or staff drinks
Monitoring Measured continuously , and documented either manually twice daily (minimum, maximum and current temperatures) or by an automated system that keeps a retrievable history
The pharmacy must follow a monitoring plan that includes:
Documented training of all personnel.
Thermometer calibration per the manufacturer.
Temperature logs kept at least three years .
Excursion details: the date and time, and the people involved in the response.
Actions taken : quarantine for destruction, or a decision that the product is safe, with the source of the information recorded (package insert, manufacturer call and so on).
A written emergency action plan , for example for a power outage.
Routine preventive maintenance of refrigeration and monitoring equipment.
The Board's self-inspection form stresses that any temperature outside the range, for any length of time, is an excursion unless the manufacturer specifies otherwise. The pharmacist reviews its duration and magnitude, and the form records which pharmacist made the final decision .
Vaccine storage (OAR 855-041-1036(3))
Pharmacies storing vaccines meet the cold-storage rules plus :
Store vaccines in the temperature-stable sections of the unit, not in door shelves or next to vents.
Use a centrally placed buffered probe thermometer (glycol or glass beads) calibrated to within ±0.5 °C .
Give each freezer and refrigerator compartment its own exterior door and independent thermostat . Dorm-style combination units don't qualify.
Use continuous temperature monitoring with automated data logging and physical confirmation. Log each active unit at least twice daily , download data weekly and validate systems quarterly . Quarterly validation is separate from thermometer calibration.
Follow a written quality-assurance process to prevent excursions.
Controlled room temperature and other conditions
For room-temperature products, follow the manufacturer's label and USP definitions. USP controlled room temperature is 20–25 °C (68–77 °F), with permitted excursions of 15–30 °C. Light-sensitive products stay in their original or light-resistant containers. Storage areas must also be kept clean and sanitary (OAR 855-041-1015). Storage must support security (section 12.3) and quarantine (section 8.8).
Storage during delivery
Because the rule covers transfers to patients , a mail-order or delivery service must use packaging and shipping methods that keep products within labeled conditions. Examples are validated cold-chain shippers for insulin and temperature indicators where appropriate. Oregon also requires appropriate storage conditions in lockers (2–8 °C or −25 to −10 °C, monitored) and kiosks (OAR 855-143, 855-141).
Disasters and power loss
During a declared emergency, OAR 855-007-0120 treats inventory damaged by fire, flood or other events as adulterated , and destroys it unless shown to be safe. A power loss that affects temperature or humidity controls requires destroying the affected drugs unless their safety can be established. A temporary closure or relocation in a declared emergency is reported to the Board within three working days , and controlled-substance losses go to DEA on the appropriate forms. Outside a declared emergency, the same storage rule applies: quarantine, evaluate with documented sources, and destroy or return anything unfit.
Warning
A refrigerator log showing a single reading of 9 °C for 20 minutes is an excursion . The pharmacist must quarantine the affected product, assess it using the manufacturer's stability data, document the decision and its source, and act on the result. Ignoring a short spike is a common inspection finding.
Exam scenario
On Monday morning a pharmacist finds that the vaccine refrigerator's data logger recorded 10.5 °C for 3 hours overnight after a power interruption. The pharmacist:
Quarantines the vaccines and labels them "do not use."
Contacts the manufacturers, and the state immunization program for any state-supplied vaccine, with the logger data.
Documents the event date and time, the staff involved, the pharmacist's review of duration and magnitude, the actions taken, the information source and the deciding pharmacist.
Product the manufacturer deems safe returns to use. The rest is destroyed or returned. The pharmacist then reviews the emergency action plan and preventive maintenance. Temperature logs are kept three years .